Go Back
Aperture Venture Partners
Aperture Venture Partners, a New York-based venture fund established in 2002, specializes in investing in the Seed to Series D stages. With a focus on BioTech, Healthcare, Medical Device, and Software sectors, the fund has invested in 53 companies and successfully exited 23. Tony Natale is a key partner at Aperture Venture Partners, overseeing investments in companies like Endotronix and Bardy Diagnostics. For more information, visit their website at www.aperturevp.com.
About
About
About
Bio
Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Location
New York
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tony Natale
Bio
Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Location
New York
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tony Natale
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Software
Number of investments
53
Number of exits
23
Fund Type
Venture Fund
Portfolio Companies
Endotronix, Bardy Diagnostics
Aperture Venture Partners
Aperture Venture Partners, a New York-based venture fund established in 2002, specializes in investing in the Seed to Series D stages. With a focus on BioTech, Healthcare, Medical Device, and Software sectors, the fund has invested in 53 companies and successfully exited 23. Tony Natale is a key partner at Aperture Venture Partners, overseeing investments in companies like Endotronix and Bardy Diagnostics. For more information, visit their website at www.aperturevp.com.
About
Bio
Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Location
New York
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tony Natale
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Software
Number of investments
53
Number of exits
23
Fund Type
Venture Fund
Portfolio Companies
Endotronix, Bardy Diagnostics